Table 1 Blastocyst development in vitro compared with basal serum AMH and selected clinical/embryology parameters among IVF patients (n = 79)
No blastocyst (n= 46) | Blastocyst (n= 33) | Difference (95% CI) | p 1 | |
|---|---|---|---|---|
Serum AMH (pmol/l) | 10.9 (3.6, 19.5) | 15.6 (10.7, 22.9) | 4.9 (0.6 to 8.9) | 0.029 |
Age (yrs) | 35.9 (33.5, 39.2) | 37.3 (33.7, 40.3) | 0.7 (-1.4 to 2.7) | 0.509 |
Terminal E2 (pmol/l) | 4084 (2996, 5164) | 7282 (3572, 10770) | 2335 (-260 to 6361) | 0.121 |
Oocytes retrieved (total n) | 7 (4, 17) | 10 (7, 13) | 3 (1, 5) | 0.004 |
MII oocytes retrieved (n) | 5 (3, 8) | 9 (6, 12) | 3 (2, 5) | 0.006 |
Early cleavage embryos (n) | 3.5 (2, 6) | 6 (5, 9) | 3 (2, 4) | 0.002 |
≥7-cell embryos on d3 (n) | 1.5 (0, 3) | 2 (1, 4) | 1 (0, 2) | 0.07 |